This inventor holds 1 USPTO granted patent. Top assignee: Janssen Oncology, Inc.. Active years: 2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2014
Title: Arie S Belldegrum: Innovator in Cancer Treatment
Introduction
Arie S Belldegrum is a notable inventor based in Los Angeles, CA, who has made significant contributions to the field of cancer treatment. With a focus on innovative methods and compositions, her work aims to improve therapeutic outcomes for cancer patients.
Latest Patents
Belldegrum holds a patent for "Methods and compositions for treating cancer." This patent describes methods for treating cancer that involve administering a 17α-hydroxylase/C-lyase inhibitor, such as abiraterone acetate, in combination with at least one additional therapeutic agent, which may include an anti-cancer agent or a steroid. The compositions disclosed in the patent also include a 17α-hydroxylase/C-lyase inhibitor along with at least one additional therapeutic agent.
Career Highlights
Belldegrum is associated with Janssen Oncology, Inc., where she continues to advance her research and development efforts in oncology. Her work is characterized by a commitment to finding effective treatments for cancer, which remains a critical area of medical research.
Collaborations
One of her notable collaborators is Alan H Auerbach, with whom she has worked closely in her research endeavors.
Conclusion
Arie S Belldegrum's innovative approaches to cancer treatment exemplify the vital role of inventors in the medical field. Her contributions through patents and collaborations continue to pave the way for advancements in oncology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile